MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s12072-020-10013-5

Медицинская библиотека · Hepatology international · 2020

Utility of N-acetylcysteine in ischemic hepatitis in cirrhotics with acute variceal bleed: a randomized controlled trial.

Maiwall Rakhi, Kumar Awinash, Bhadoria Ajeet Singh, Jindal Ankur, Kumar Guresh, Bhardwaj Ankit, Maras Jaswinder Singh, Sharma Manoj Kumar, Sharma Barjesh Chandra, Sarin Shiv Kumar

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

BACKGROUND AND AIMS: Ischemic hepatitis (IH) following acute variceal bleed (AVB) carries an ominous prognosis. N-Acetylcysteine (NAC), a potent anti-oxidant, may prevent IH by improving tissue oxygen delivery and improving hepatic hypoxia.

METHODS

Consecutive cirrhotics with AVB were prospectively randomized to receive either standard of care (SOC) plus NAC intravenously for 72 h(at 150 mg/kg/h for 1 h followed by 12.5 mg/kg/h for 4 h, followed by 6.25 mg/kg for 67 h) (Group A, n = 107) or SOC alone (Group B, n = 107).

RESULTS

Baseline characteristics were comparable. IH developed more frequently in Gr.B 25(23%) than A-15(14%); p = 0.08). Incidence of IH increased with severity of liver disease. Binary logistic regression analysis showed reduced incidence of IH in Gr.A than B [odds ratio (OR) 0.33, 0.11-0.93] patients after controlling for other significant factors. The incidence of acute kidney injury (AKI) was also reduced in Gr.A [OR 0.34, 0.15-0.75]. Development of IH was significantly associated with increased deaths due to liver failure at 6 weeks [subdistribution hazard ratio (SHR) 21.6, 7.4-62.8]. On multivariate competing risk analysis, significantly lower deaths due to liver failure (SHR 0.33, 0.11-0.97) were noted in Gr.A than B.

CONCLUSIONS

One in five patients with acute variceal bleed develops ischemic hepatitis which is associated with worse outcomes. NAC therapy averts deaths due to liver failure by preventing IH and reduces AKI and is, therefore, recommended for cirrhotics with acute variceal bleed.

TRIAL REGISTRATION: Clinicaltrials.gov no: NCT02015403.

Для цитирования: Maiwall Rakhi, Kumar Awinash, Bhadoria Ajeet Singh, Jindal Ankur, Kumar Guresh, Bhardwaj Ankit, Maras Jaswinder Singh, Sharma Manoj Kumar, Sharma Barjesh Chandra, Sarin Shiv Kumar. Utility of N-acetylcysteine in ischemic hepatitis in cirrhotics with acute variceal bleed: a randomized controlled trial.. Hepatology international. 2020. DOI: 10.1007/s12072-020-10013-5.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.